Search - tctmd.com

Displaying 641 - 660 of 826

Sort: Relevancy | Date

Presentation TCT 2017

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Presenter: David H. Adams, Ted Feldman, Gilles Dreyfus

October 30, 2017

Presentation TCT 2017

Mitral Valve Disease and TMV Repair and Replacement: Progress and Obstacles

Presenter: Russell A. Brandwein, Elizabeth M. Perpetua

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey V: Addressing Complications and Follow-up

Presenter: Martina Kelly Speight, Amy E. Simone

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Craig R. Smith

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey IV: The Hospital Experience

Presenter: Martina Kelly Speight, Sandra Lauck

October 30, 2017

Presentation TCT 2017

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Presenter: A. Pieter Kappetein

October 30, 2017

Presentation TCT 2017

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

Presenter: Susheel K. Kodali

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey III: Behind the Scenes

Presenter: Martina Kelly Speight, Sarah Clarke

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey II: Imaging Assessment

Presenter: Martina Kelly Speight, João L Cavalcante

October 30, 2017

Presentation TCT 2017

TAVR Patient Journey I: Initial Evaluation

Presenter: Martina Kelly Speight, Patricia Keegan

October 30, 2017

Presentation TCT 2017

Step-By-Step LAA Occlusion Implantation Technique (Case-based)

Presenter: Alexandre Abizaid, Oscar A. Mendiz, Ricardo Quizhpe

October 29, 2017

Presentation TCT 2017

Step-By-Step MitraClip Implantation Technique (Case-based)

Presenter: Alexandre Abizaid, Oscar A. Mendiz, Marco Alcantara

October 29, 2017

Presentation TCT 2017

Step-By-Step TAVR Implantation Technique (Case-based)

Presenter: Alexandre Abizaid, Oscar A. Mendiz

October 29, 2017

Presentation TCT 2017

Interventional Pathobiology: A Practical Anatomical Description for SHD Procedures

Presenter: Alexandre Abizaid, Oscar A. Mendiz, Juan F. Granada

October 29, 2017

Presentation TCT 2017

CT Imaging Analysis for TAVR Procedures: Step-By-Step Approach

Presenter: Alexandre Abizaid, Oscar A. Mendiz, Nicolo Piazza

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News TCT 2016

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Yael L. Maxwell

November 02, 2016

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Advertisement

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Mitral Valve Disease and TMV Repair and Replacement: Progress and Obstacles

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

TAVR Patient Journey V: Addressing Complications and Follow-up

Predicting the Future: Will the Ongoing LOW RISK TAVR Trials Change How We Treat Low Surgical Risk Patients With Aortic Stenosis?

TAVR Patient Journey IV: The Hospital Experience

TAVR should be reserved for intermediate and higher-risk tricuspid valve aortic stenosis!

Were ready to treat bicuspid valve and lower-risk tricuspid valve aortic stenosis!

TAVR Patient Journey III: Behind the Scenes

TAVR Patient Journey II: Imaging Assessment

TAVR Patient Journey I: Initial Evaluation

Step-By-Step LAA Occlusion Implantation Technique (Case-based)

Step-By-Step MitraClip Implantation Technique (Case-based)

Step-By-Step TAVR Implantation Technique (Case-based)

Interventional Pathobiology: A Practical Anatomical Description for SHD Procedures

CT Imaging Analysis for TAVR Procedures: Step-By-Step Approach

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content